Safety of gadoterate meglumine (Gd-DOTA) as a contrast agent for magnetic resonance imaging: results of a post-marketing surveillance study in Japan

Safety of gadoterate meglumine (Gd-DOTA) as a contrast agent for magnetic resonance imaging: results of a post-marketing surveillance study in Japan

Item
http://www.wikidata.org/entity/Q36649891
N-acetylcysteine protects rats with chronic renal failure from gadolinium-chelate nephrotoxicity.An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis.Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)Safety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million ApplicationsSafety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study.Safety and efficacy of gadoteric acid in pediatric magnetic resonance imaging: overview of clinical trials and post-marketing studies.Observational study on the safety profile of gadoterate meglumine in 35,499 patients: The SECURE study.Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.Inter- and intra-individual comparative study of two gadolinium-based agents: A pilot study.Single-Dose Gadoterate Meglumine for 3T Late Gadolinium Enhancement MRI for the Assessment of Chronic Myocardial Infarction: Intra-Individual Comparison with Conventional Double-Dose 1.5T MRI.Vascular CT and MRI: a practical guide to imaging protocols.
P2860

Safety of gadoterate meglumine (Gd-DOTA) as a contrast agent for magnetic resonance imaging: results of a post-marketing surveillance study in Japan

Item
http://www.wikidata.org/entity/Q36649891
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Safety of gadoterate meglumine ...... ng surveillance study in Japan
@ast
Safety of gadoterate meglumine ...... ng surveillance study in Japan
@en
type
label
Safety of gadoterate meglumine ...... ng surveillance study in Japan
@ast
Safety of gadoterate meglumine ...... ng surveillance study in Japan
@en
prefLabel
Safety of gadoterate meglumine ...... ng surveillance study in Japan
@ast
Safety of gadoterate meglumine ...... ng surveillance study in Japan
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Safety of gadoterate meglumine ...... ng surveillance study in Japan
@en
P2093
P2860
P304
P31
P356
10.2165/11539140-000000000-00000
P433
P478
P577
P5875
P698
P932